Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...

Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

Jeff Yass is now the 25th wealthiest person in the world — and other highlights from Forbes Billionaires list.

You've done your due diligence. You found the right tax software, accountant or did the taxes yourself. And after crunching the numbers, you've discovered you're getting a tax refund. Success!

Feathered friends got caught up in President Donald Trump’s trade war, Beatlemania might be making a comeback, and some big changes are coming to the world of sports. Test your knowledge of the ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Senate Republicans are setting up a major gamble to renew President Donald Trump’s signature tax cuts later this year. In rolling out their new budget blueprint on Wednesday, GOP senators opted ...

MSNBC’s Lawrence O’Donnell explains how four Senate Republicans said “loud and clear” with their vote to undo Donald Trump’s tariffs on Canada that “tariffs are taxes” on the same ...